Effect of continuous saline bladder irrigation with concomitant single instillation of chemotherapy after transurethral resection on intravesical recurrence in patients with non-muscle-invasive bladder cancer

被引:5
|
作者
Kuroda, Kenji [1 ]
Tasaki, Shinsuke [1 ]
Sato, Akinori [1 ]
Asakuma, Junichi [1 ]
Horiguchi, Akio [1 ]
Ito, Keiichi [1 ]
机构
[1] Natl Def Med Coll, Dept Urol, 3-2 Namiki, Tokorozawa, Saitama 3598513, Japan
关键词
bladder cancer; continuous saline bladder irrigation; non-muscle-invasive bladder cancer; intravesical recurrence; IMMEDIATE POSTOPERATIVE INSTILLATION; PROGRESSION; GUIDELINES; RISK;
D O I
10.3892/mco.2020.2079
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
A single immediate instillation of chemotherapy following transurethral resection of bladder tumor (TURBT) is effective in preventing intravesical recurrence (IVR) in patients with non-muscle-invasive urothelial bladder carcinoma (NMIBC). However, continuous saline bladder irrigation (CSBI) is also performed with a single instillation of chemotherapy (SIC), but its inhibitory effect on IVR remains unclear. In the present study, the effect of CSBI with concomitant SIC following TUR on IVR was evaluated in patients with NMIBC. A retrospective review of 253 patients who underwent TURBT and were clinically and histologically diagnosed with NMIBC at National Defense Medical College Hospital was performed. Doxorubicin (DXR) was administered to all patients. Methods of DXR administration included a single instillation of DXR (60 mg in 30-40 ml saline) in 34 patients (group A), continuous irrigation of the bladder with saline including DXR (80 mg in 1 liter saline) in 40 patients (group B) and overnight CSBI after a single instillation of DXR in 179 patients (group C). The difference in IVR-free survival rates was compared after adjusting for significant differences in several covariates between the groups by nearest-neighbor propensity score matching. Prior to propensity score matching, it was identified that time to IVR was significantly longer in group A than in groups B and C; however, it was observed that several factors significantly differed among the three groups. By using nearest neighbor matching, 18 pairs were matched between groups A and B and 33 pairs between the groups A and C. No significant difference was identified in any covariates between these two matched group pairsTime to IVR was significantly longer in the matched group A than in the matched groups B and C (P=0.0255 and P=0.0023, respectively). In conclusion, SIC alone could provide a higher IVR-free survival rate than CSBI with DXR or CSBI with SIC.
引用
收藏
页码:1 / 8
页数:8
相关论文
共 50 条
  • [41] Intravesical treatment of non-muscle-invasive bladder cancer
    Bahlburg, Henning
    Noldus, Joachim
    Roghmann, Florian
    UROLOGIE, 2025,
  • [42] Predictive Factors for Residual Cancer in Second Transurethral Resection for Non-muscle-invasive Bladder Cancer
    Akitake, Masakazu
    Yamaguchi, Akito
    Shiota, Masaki
    Imada, Kenjiro
    Tatsugami, Katsunori
    Yokomizo, Akira
    Naito, Seiji
    Eto, Masatoshi
    ANTICANCER RESEARCH, 2019, 39 (08) : 4325 - 4328
  • [43] Repeat Transurethral Resection in Non-muscle-invasive Bladder Cancer: A Systematic Review
    Cumberbatch, Marcus G. K.
    Foerster, Beat
    Catto, James W. F.
    Kamat, Ashish M.
    Kassouf, Wassim
    Jubber, Ibrahim
    Shariat, Shahrokh F.
    Sylvester, Richard J.
    Gontero, Paolo
    EUROPEAN UROLOGY, 2018, 73 (06) : 925 - 933
  • [44] Oncological outcomes of a single but extensive transurethral resection followed by appropriate intra-vesical instillation therapy for newly diagnosed non-muscle-invasive bladder cancer
    Koie, Takuya
    Ohyama, Chikara
    Hosogoe, Shogo
    Yamamoto, Hayato
    Imai, Atsushi
    Hatakeyama, Shingo
    Yoneyama, Takahiro
    Hashimoto, Yasuhiro
    Yoneyama, Tohru
    Tobisawa, Yuki
    Mori, Kazuyuki
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2015, 47 (09) : 1509 - 1514
  • [45] Patients with Non-Muscle-Invasive Bladder Cancer Previously Treated with Nephroureterectomy Have a High Risk of Recurrence after Bacillus Calmette-Guérin Intravesical Instillation Therapy
    Maeyama, Ryota
    Ikeda, Masaomi
    Shimura, Soichiro
    Amano, Noriyuki
    Murakami, Yasukiyo
    Yamada, Yasufumi
    Koguchi, Dai
    Tachibana, Takashi
    Kawamura, Mizuho
    Sakata, Yusuke
    Hagiwara, Masahiro
    Matsumoto, Kazumasa
    Iwamura, Masatsugu
    CHEMOTHERAPY, 2023, 68 (04) : 190 - 196
  • [46] Impact of repeat transurethral resection on treatment results in patients with non-muscle-invasive bladder cancer
    Khalmurzayer, O. A.
    Marco, V. B.
    Figurin, R. M.
    Romano, V. A.
    Panakhor, A. D.
    Khafizor, K. O.
    ONKOUROLOGIYA, 2012, 8 (04): : 33 - 39
  • [47] Comparison of Thulium Laser Resection of Bladder Tumors and Conventional Transurethral Resection of Bladder Tumors for Non-Muscle-Invasive Bladder Cancer
    Liu, Zheng
    Zhang, Yucong
    Sun, Guoliang
    Ouyang, Wei
    Wang, Shen
    Xu, Hao
    Hu, Henglong
    Li, Fan
    Yang, Jun
    Wang, Zhihua
    Guan, Wei
    Yu, Xiao
    Hu, Zhiquan
    Chen, Zhong
    Wang, Shaogang
    Long, Gongwei
    Li, Heng
    UROLOGIA INTERNATIONALIS, 2022, 106 (02) : 116 - 121
  • [48] Effects of transurethral resection under general anesthesia on tumor recurrence in non-muscle invasive bladder cancer
    Baba, Yuto
    Kikuchi, Eiji
    Shigeta, Keisuke
    Ogihara, Koichiro
    Matsushima, Masashi
    Nishimoto, Yui
    Murata, Yasuaki
    Asakura, Hirotaka
    Oyama, Masafumi
    Mizuno, Ryuichi
    Oya, Mototsugu
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2021, 26 (11) : 2094 - 2103
  • [49] Effect of HLA genotype on intravesical recurrence after bacillus Calmette-Guerin therapy for non-muscle-invasive bladder cancer
    Kobayashi, Mizuki
    Fujiyama, Nobuhiro
    Tanegashima, Tokiyoshi
    Narita, Shintaro
    Yamamoto, Yoshiaki
    Fujimoto, Naohiro
    Ueda, Shohei
    Takeuchi, Ario
    Numakura, Kazuyuki
    Habuchi, Tomonori
    Matsuyama, Hideyasu
    Eto, Masatoshi
    Shiota, Masaki
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2022, 71 (03) : 727 - 736
  • [50] Effect of HLA genotype on intravesical recurrence after bacillus Calmette–Guérin therapy for non-muscle-invasive bladder cancer
    Mizuki Kobayashi
    Nobuhiro Fujiyama
    Tokiyoshi Tanegashima
    Shintaro Narita
    Yoshiaki Yamamoto
    Naohiro Fujimoto
    Shohei Ueda
    Ario Takeuchi
    Kazuyuki Numakura
    Tomonori Habuchi
    Hideyasu Matsuyama
    Masatoshi Eto
    Masaki Shiota
    Cancer Immunology, Immunotherapy, 2022, 71 : 727 - 736